KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Debt to Equity (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Debt to Equity for 17 consecutive years, with $0.59 as the latest value for Q4 2025.

  • Quarterly Debt to Equity rose 14.71% to $0.59 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.59 through Dec 2025, up 14.71% year-over-year, with the annual reading at $0.59 for FY2025, 14.71% up from the prior year.
  • Debt to Equity hit $0.59 in Q4 2025 for Johnson & Johnson, up from $0.58 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.75 in Q2 2023 to a low of $0.42 in Q4 2023.
  • Historically, Debt to Equity has averaged $0.53 across 5 years, with a median of $0.51 in 2021.
  • Biggest five-year swings in Debt to Equity: soared 147.48% in 2021 and later tumbled 35.66% in 2024.
  • Year by year, Debt to Equity stood at $0.48 in 2021, then dropped by 11.08% to $0.43 in 2022, then dropped by 0.66% to $0.43 in 2023, then rose by 20.15% to $0.51 in 2024, then grew by 14.71% to $0.59 in 2025.
  • Business Quant data shows Debt to Equity for JNJ at $0.59 in Q4 2025, $0.58 in Q3 2025, and $0.65 in Q2 2025.